Propanc Biopharma Inc.
PPCB | NASDAQ
$1.84
-$0.27 (-12.80%)
At close: Oct 30, 2026, 4:00 PM ET
$1.94
+$0.10 (+5.20%)
Pre-market:
Nov 2, 2026, 7:55 AM ET
Fiscal Quarter Period Ending | Q4 2026 Jun 30, 2026 | Q3 2026 Mar 31, 2026 | Q2 2026 Dec 31, 2025 | Q1 2026 Sep 30, 2025 | Q4 2025 Jun 30, 2025 | Q3 2025 Mar 31, 2025 | Q2 2025 Dec 31, 2024 | Q1 2025 Sep 30, 2024 | Q4 2024 Jun 30, 2024 | Q3 2024 Mar 31, 2024 | Q2 2024 Dec 31, 2023 | Q1 2024 Sep 30, 2023 | Q4 2023 Jun 30, 2023 | Q3 2023 Mar 31, 2023 | Q2 2023 Dec 31, 2022 | Q1 2023 Sep 30, 2022 | Q4 2022 Jun 30, 2022 | Q3 2022 Mar 31, 2022 | Q2 2022 Dec 31, 2021 | Q1 2022 Sep 30, 2021 | Q4 2021 Jun 30, 2021 | Q3 2021 Mar 31, 2021 | Q2 2021 Dec 31, 2020 | Q1 2021 Sep 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 832.01K | 443.7K | 561.24K | 602.74K | 12.09K | 50.76K | 14.63K | 9.27K | 21.09K | 6.22K | 71.65K | 6.63K | 10.05K | 93.24K | 24.48K | 19.4K | 4.07K | 133.89K | 73.62K | 45.82K | 2.26K | 14.44K | 21.24K | 51.22K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 4.19M | 6.06M | 7.35M | 9.15M | 11.22M | 12.79M | 53.97K | 29.2K | 29.13K | 1.96K | 2.04K | 1.93K | 2K | 2.01K | 2.04K | 1.93K | 2.08K | 22.25K | 22.18K | 2.16K | 2.25K | 2.29K | 2.31K | 2.15K |
Receivables | 13.69K | 11.06K | 16.99K | 8.38K | 5.3K | 3.63K | 1.97K | 3.31K | 2.95K | 5.27K | 127.04K | 2.63K | 2.87K | 3.33K | 4.54K | 2.7K | 2.34K | 2.22K | 5.63K | 2.24K | 4.34K | 4.08K | 1.94K | 2.85K |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 34.92K | 35.11K | 1.4K | 8.83K | 1.38K | 1.31K | 1.38K | 8.96K | 1.41K | 1.37K | 12.14K | 136.55K | 6.13K | 0 | 25.21K | 15.77K | 8.62K | 8.41K | 5.64K | 8.35K | n/a | 0 | 0 | 0 |
Total Current Assets | 8.54M | 8.22M | 7.71M | 8.76M | 8.35M | 9.74M | 17.98K | 21.53K | 25.44K | 12.86K | 210.82K | 145.8K | 19.04K | 96.58K | 54.23K | 37.86K | 15.03K | 144.51K | 84.88K | 56.41K | 6.6K | 18.52K | 23.18K | 54.07K |
Property-Plant & Equipment | 44.7K | 50.8K | 55.3K | 58.64K | 59.41K | 1.66K | 6.58K | 12.91K | 17.8K | 22.53K | 29.04K | 32.64K | 39.29K | 45.16K | 51.75K | 54.46K | 64.55K | 2.71K | 3.12K | 3.59K | 4.26K | 7.24K | 15.12K | 21.33K |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 4.24M | 6.11M | 7.4M | 9.21M | 11.28M | 12.79M | 60.55K | 42.11K | 46.92K | 24.48K | 31.08K | 34.57K | 41.29K | 47.17K | 53.8K | 56.39K | 66.62K | 24.95K | 25.3K | 5.76K | 6.51K | 9.53K | 17.43K | 23.48K |
Total Assets | 12.78M | 14.33M | 15.11M | 17.98M | 19.63M | 22.53M | 78.53K | 63.64K | 72.37K | 37.34K | 241.91K | 180.37K | 60.33K | 143.74K | 108.02K | 94.25K | 81.65K | 169.46K | 110.18K | 62.17K | 13.1K | 28.04K | 40.62K | 77.55K |
Account Payables | 1.13M | 973.69K | 957.48K | 1.07M | 1.25M | 1.12M | 1.22M | 1.24M | 1.21M | 1.19M | 1.16M | 1.21M | 966.72K | 918.2K | 986.9K | 899.23K | 943.02K | 967.21K | 920.69K | 826.18K | 1M | 950.13K | 1.02M | 929.83K |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 485.3K | 543.61K | 592.36K | 632.49K | 1.56M | 1.15M | 1.12M | 1.02M | 870.27K | 861.07K | 951.78K | 478.7K | 460.69K | 593.7K | 710.58K | 879.24K | 947.04K | 1.02M | 920.12K | 547.26K | 590.49K | 932.57K | 1.16M | 979.02K |
Other Current Liabilities | 844.05K | 1.08M | 1.02M | 854.74K | 1.07M | 816.45K | 742.9K | 812.14K | 773.26K | 738.77K | 843.7K | 868.01K | 1.14M | 968.44K | 716.63K | 646.8K | 757.12K | 689.51K | 780.92K | 588.71K | 1.07M | 724.92K | 1.05M | 1.03M |
Total Current Liabilities | 3.35M | 3.48M | 3.62M | 3.57M | 5.58M | 4.34M | 4.15M | 4.1M | 3.79M | 3.69M | 3.76M | 3.13M | 3.16M | 3.06M | 2.99M | 2.82M | 3.06M | 3.12M | 3.04M | 2.37M | 3.08M | 3.03M | 3.65M | 3.31M |
Long-Term Debt | n/a | 1M | n/a | n/a | 105.63K | 93.91K | 82.33K | 70.49K | 58.64K | 46.93K | 35.21K | 23.37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 23.82K | 1.03M | 35.25K | 42.08K | 147.38K | 93.91K | 82.33K | 70.49K | 58.64K | 48.87K | 43.26K | 36.52K | 19.28K | 24.94K | 30.89K | 39.36K | 42.32K | n/a | 0 | n/a | n/a | n/a | n/a | n/a |
Total Liabilities | 3.38M | 4.51M | 3.66M | 3.61M | 5.73M | 4.44M | 4.24M | 4.17M | 3.85M | 3.74M | 3.81M | 3.17M | 3.18M | 3.09M | 3.02M | 2.86M | 3.11M | 3.12M | 3.04M | 2.37M | 3.08M | 3.03M | 3.65M | 3.31M |
Total Debt | 509.12K | 1.57M | 649.22K | 695.07K | 1.73M | 1.25M | 1.21M | 1.1M | 948.27K | 932.26K | 1.02M | 515.22K | 479.97K | 618.63K | 741.46K | 918.6K | 989.36K | 1.02M | 920.12K | 547.26K | 590.49K | 932.57K | 1.16M | 979.02K |
Book Value | 9.4M | 9.83M | 11.45M | 14.36M | 13.91M | 18.09M | -4.16M | -4.11M | -3.78M | -3.7M | -3.56M | -2.99M | -3.12M | -2.94M | -2.92M | -2.77M | -3.02M | -2.95M | -2.93M | -2.31M | -3.07M | -3M | -3.61M | -3.24M |
Book Value Per Share | 83.67 | 153.82 | 214.30 | 291.15 | 876.09 | 1.05K | -7.79K | -83.84K | -23.04K | -50.68K | -2.24M | -4.08M | -1.79 | -111M | -60.88M | -87.66M | -0.04 | -1.11K | -1.15B | -1.27B | -5.46K | -50.29B | -100.22K | -81.25B |
Common Stock | 3.31K | 21.86K | 13.46K | 13.33K | 11.62K | 11.61K | 14 | 688.02K | 478.8K | 109.71K | 36.17K | 14.83K | 6.03K | 2.62M | 1.25M | 677.18K | 220.35K | 85.03K | 53.06K | 43.84K | 14.06K | 4.97K | 1.45K | 715.6K |
Retained Earnings | -144.48M | -140.84M | -134.48M | -130.46M | -125.62M | -121.55M | -67.48M | -67.05M | -66.7M | -66.34M | -65.8M | -65.18M | -64.68M | -63.88M | -63.07M | -62.56M | -61.56M | -60.4M | -59.7M | -58.8M | -58.2M | -57.03M | -56.61M | -56.21M |
Comprehensive Income | 1.18M | 1.27M | 1.33M | 1.34M | 1.32M | 1.46M | 1.49M | 1.17M | 1.27M | 1.34M | 1.23M | 1.37M | 1.3M | 1.29M | 1.25M | 1.36M | 1.23M | 1.09M | 1.14M | 1.05M | 1.09M | 1.05M | 1.02M | 1.19M |
Shareholders Equity | 9.4M | 9.83M | 11.45M | 14.36M | 13.91M | 18.09M | -4.16M | -4.11M | -3.78M | -3.7M | -3.56M | -2.99M | -3.12M | -2.94M | -2.92M | -2.77M | -3.02M | -2.95M | -2.93M | -2.31M | -3.07M | -3M | -3.61M | -3.24M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove PPCB